These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23448115)

  • 41. Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States.
    Helmuth ME; Liu Q; Turenne MN; Park JM; Oguntimein M; Dutcher SK; Balkrishnan R; Sharma P; Zee J; Leichtman AB; Smith AR
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):421-430. PubMed ID: 30819667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness of full coverage of aromatase inhibitors for Medicare beneficiaries with early breast cancer.
    Ito K; Elkin E; Blinder V; Keating N; Choudhry N
    Cancer; 2013 Jul; 119(13):2494-502. PubMed ID: 23775433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost effectiveness of paliperidone palmitate for the treatment of schizophrenia in Germany.
    Zeidler J; Mahlich J; Greiner W; Heres S
    Appl Health Econ Health Policy; 2013 Oct; 11(5):509-21. PubMed ID: 23975630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Review of outcomes associated with restricted access to atypical antipsychotics.
    Rajagopalan K; Hassan M; Boswell K; Sarnes E; Meyer K; Grossman F
    Am J Manag Care; 2016 Jun; 22(6):e208-14. PubMed ID: 27355908
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in Medicaid.
    Seabury SA; Goldman DP; Kalsekar I; Sheehan JJ; Laubmeier K; Lakdawalla DN
    Am J Manag Care; 2014 Feb; 20(2):e52-60. PubMed ID: 24738555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Balancing therapeutic safety and efficacy to improve clinical and economic outcomes in schizophrenia: a managed care perspective.
    Liu J
    Am J Manag Care; 2014 Jun; 20(8 Suppl):S174-83. PubMed ID: 25180707
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: results of a Markov model analysis.
    Fajutrao L; Paulsson B; Liu S; Locklear J
    Clin Ther; 2009 Jun; 31 Pt 1():1456-68. PubMed ID: 19698903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap.
    Polinski JM; Shrank WH; Huskamp HA; Glynn RJ; Liberman JN; Schneeweiss S
    PLoS Med; 2011 Aug; 8(8):e1001075. PubMed ID: 21857811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents.
    Sacks CA; Lee CC; Kesselheim AS; Avorn J
    JAMA; 2018 Aug; 320(7):650-656. PubMed ID: 30140875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmaco-utilisation and related costs of drugs used to treat schizophrenia and bipolar disorder in Italy: the IBIS study.
    Degli Esposti L; Sangiorgi D; Mencacci C; Spina E; Pasina C; Alacqua M; la Tour F
    BMC Psychiatry; 2014 Oct; 14():282. PubMed ID: 25312446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impacts of generic competition and benefit management practices on spending for prescription drugs: evidence from Medicare's Part D benefit.
    Sheingold S; Nguyen NX
    Medicare Medicaid Res Rev; 2014; 4(1):. PubMed ID: 24918023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
    Woodward TC; Tafesse E; Quon P; Lazarus A
    Pharmacoeconomics; 2010; 28(9):751-64. PubMed ID: 20623994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage.
    Simoni-Wastila L; Zuckerman IH; Shaffer T; Blanchette CM; Stuart B
    Health Serv Res; 2008 Apr; 43(2):496-514. PubMed ID: 18370965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atypical antipsychotic agents in the treatment of Schizophrenia and other psychiatric disorders. Part II: Special considerations.
    J Clin Psychiatry; 1998 Jun; 59(6):322-8. PubMed ID: 9671350
    [No Abstract]   [Full Text] [Related]  

  • 55. Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries.
    Sumarsono A; Sumarsono N; Das SR; Vaduganathan M; Agrawal D; Pandey A
    JAMA Netw Open; 2020 Feb; 3(2):e200181. PubMed ID: 32108893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quetiapine: a pharmacoeconomic review of its use in bipolar disorder.
    Plosker GL
    Pharmacoeconomics; 2012 Jul; 30(7):611-31. PubMed ID: 22559293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness of atypical antipsychotics for the management of schizophrenia in the UK .
    Davies A; Vardeva K; Loze JY; L'italien GJ; Sennfalt K; Baardewijk Mv
    Curr Med Res Opin; 2008 Nov; 24(11):3275-85. PubMed ID: 18947458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK.
    Tempest M; Sapin C; Beillat M; Robinson P; Treur M
    J Ment Health Policy Econ; 2015 Dec; 18(4):185-200. PubMed ID: 26729007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of the Medicare Part D prescription benefit on generic drug use.
    Zhang JX; Yin W; Sun SX; Alexander GC
    J Gen Intern Med; 2008 Oct; 23(10):1673-8. PubMed ID: 18661190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trends in Utilization and Cost of Low-Density Lipoprotein Cholesterol-Lowering Therapies Among Medicare Beneficiaries: An Analysis From the Medicare Part D Database.
    Sumarsono A; Lalani HS; Vaduganathan M; Navar AM; Fonarow GC; Das SR; Pandey A
    JAMA Cardiol; 2021 Jan; 6(1):92-96. PubMed ID: 32902560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.